398 related articles for article (PubMed ID: 25065885)
1. IAP family of cell death and signaling regulators.
Silke J; Vucic D
Methods Enzymol; 2014; 545():35-65. PubMed ID: 25065885
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
3. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
de Almagro MC; Goncharov T; Newton K; Vucic D
Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
5. Immunoblot Analysis of the Regulation of TNF Receptor Family-Induced NF-κB Signaling by c-IAP Proteins.
Varfolomeev E; Goncharov T; Vucic D
Methods Mol Biol; 2021; 2366():109-123. PubMed ID: 34236635
[TBL] [Abstract][Full Text] [Related]
6. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
[TBL] [Abstract][Full Text] [Related]
7. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.
Yang QH; Du C
J Biol Chem; 2004 Apr; 279(17):16963-70. PubMed ID: 14960576
[TBL] [Abstract][Full Text] [Related]
8. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.
Varfolomeev E; Goncharov T; Fedorova AV; Dynek JN; Zobel K; Deshayes K; Fairbrother WJ; Vucic D
J Biol Chem; 2008 Sep; 283(36):24295-9. PubMed ID: 18621737
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2.
Csomos RA; Brady GF; Duckett CS
J Biol Chem; 2009 Jul; 284(31):20531-9. PubMed ID: 19506082
[TBL] [Abstract][Full Text] [Related]
10. c-IAP ubiquitin protein ligase activity is required for 4-1BB signaling and CD8(+) memory T-cell survival.
Giardino Torchia ML; Munitic I; Castro E; Herz J; McGavern DB; Ashwell JD
Eur J Immunol; 2015 Sep; 45(9):2672-82. PubMed ID: 26096449
[TBL] [Abstract][Full Text] [Related]
11. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
[TBL] [Abstract][Full Text] [Related]
12. Roles of c-IAP proteins in TNF receptor family activation of NF-κB signaling.
Varfolomeev E; Goncharov T; Vucic D
Methods Mol Biol; 2015; 1280():269-82. PubMed ID: 25736754
[TBL] [Abstract][Full Text] [Related]
13. Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.
Yang W; Cooke M; Duckett CS; Yang X; Dorsey JF
Cell Cycle; 2014; 13(6):992-1005. PubMed ID: 24552816
[TBL] [Abstract][Full Text] [Related]
14. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
[TBL] [Abstract][Full Text] [Related]
16. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
de Almagro MC; Vucic D
Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
[TBL] [Abstract][Full Text] [Related]
17. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1).
Lee S; Challa-Malladi M; Bratton SB; Wright CW
J Biol Chem; 2014 Oct; 289(44):30680-30689. PubMed ID: 25246529
[TBL] [Abstract][Full Text] [Related]
19. A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation.
Hornburger MC; Mayer BA; Leonhardt S; Willer EA; Zahler S; Beyerle A; Rajalingam K; Vollmar AM; Fürst R
FASEB J; 2014 Apr; 28(4):1938-46. PubMed ID: 24371121
[TBL] [Abstract][Full Text] [Related]
20. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance.
Silke J; Kratina T; Chu D; Ekert PG; Day CL; Pakusch M; Huang DC; Vaux DL
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16182-7. PubMed ID: 16263936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
